Medicare Drug Plan Cost For Jakafi
Below is your cost or co-pay for Jakafi in Bronx County New York. The chart includes the plans premium and deductible for every plan that offers additions coverage for Jakafi. You can also see if each plan requires Prior Authorization, Step Therapy or has Drug Quantity limit for Jakafi. Please check the formulary for different brand and generic drug names. Every Medicare Advantage and Medicare Part-D plan will vary on covereage, co-pays, cost and premiums. Knowing every plans details will help you get the best coverage and the cheapest prices for your medications in Bronx County New York.
| Drug: |
|---|
Most plans have 4 levels of coverage. The exception is the $0 Deductible Plans.1.Pre-Deductable: Before you reach the plans deductible. Some plans offer select Pre-deductible drug Coverage.2.Initial Coverage Limit: After you reach the plans deductible but before the Initial Coverage limit.3.Coverage Gap: After you reach the plans ICL but before the Catastrophic of $6350 in 2020.4.Catastrophic: Anything over $6350 you will receive a significant increase in coverage.
Definitions:
What if a drug I need is not listed?
How To Enroll In Incytecares For Jakafi
- Call IncyteCARES to get started at
- Ask your prescribing Healthcare Professional to enroll you
Note that not all patients who have been prescribed Jakafi are eligible to enroll in IncyteCARES or to receive all services we provide.
Hear from real patients who discuss their individual experiences with Jakafi and IncyteCARES.
Register for the Incyte Mentor Program and connect with another patient taking Jakafi.
Email Address
Register for the Incyte MentorProgram and connect with another patient taking Jakafi.
INDICATIONS AND USAGE
INDICATIONS AND USAGE
Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.
Jakafi is used to treat adults with certain types of myelofibrosis.
Jakafi is used to treat adults and children 12 years of age and older with acute graft-versus-host disease who have taken corticosteroids and they did not work well enough.
Jakafi is also used to treat adults and children 12 years of age and older with chronic GVHD who have taken one or two types of treatments and they did not work well enough.
Important Safety Information
Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.
Medicare Website Privacy Policyprivacy Policy
Thank you for visiting www.medicarebenefits.com website , which is owned and operated by Medicare Benefits Solutions, herein after referred to as Medicare Benefits “We” or “Our”, which is a brand operated by Health Compare Insurance Services Inc. Your privacy is important to us. To better protect your privacy, We are providing this notice explaining Our online information policies and practices. By visiting this Websites, you are consenting to the practices described in this privacy policy.
Effective Date of This Privacy Policy This privacy policy is effective October 1, 2009.
Categories of Personally Identifiable Information We Collect. Medicare Benefits will receive and store information about you and your dependents such as name, address, gender, Social Security Number, age and answers to medical questions whenever this information is provided through these Websites. We may also obtain information about you from third parties such as your employer or insurance brokers who may utilize these Websites to do such things as request a quote for health insurance coverage or manage account activity online.
Log FilesThese Websites records the IP or internet protocol address of users who log on to facilitate use of these Websites. IP addresses are not linked to personally identifiable information.
Read Also: What To Do Before You Turn 65 Medicare
How Many And Which Drugs Had Average Out
- In 2019, there were 154 drugs where Medicare Part D enrollees incurred average annual out-of-pocket costs for that one drug alone greater than $2,000, including 108 drugs where average annual out-of-pocket costs exceeded $3,100.
- While some of these high-priced drugs are treatments for rare diseases that are taken by a relatively small number of Part D enrollees, the out-of-pocket cost for individual patients taking these drugs can be substantial. For example, average out-of-pocket spending was $42,440 for Strensiq, which treats a rare metabolic disease called hypophosphatasia $15,108 for Takhzyro, a treatment for hereditary angioedema and $13,090 for Firdapse, a treatment for Lambert-Eaton myasthenic syndrome , a rare muscle disease. It is important to note that these spending estimates do not include additional out-of-pocket costs that users of these 154 drugs incurred for other medications, so the total out-of-pocket cost burden in 2019 for users of these drugs was likely higher, suggesting that the savings associated with proposed caps on out-of-pocket spending would be even greater than the amount associated with a given relatively high-priced drug.
Jakafi Coupons And Rebates
Jakafi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples.Some offers may be printed right from a website, others require registration, completing a questionnaire,or obtaining a sample from the doctor’s office.
Jakafi Patient Copay/Coinsurance Assistance: Eligible commercially insured patients may pay as little as $0 per month with savings of up to $25,000 per year for additional information contact the program at 855-452-5234.
- Applies to:
Applicable drugs:
More information please phone:800-675-8416Visit Website
Read Also: Is Medicare The Best Insurance
Incytecares For Jakafi Patient Support Program
At IncyteCARES for Jakafi, our mission is to help eligible patients get started with their medicine and to provide information and support throughout their treatment.
We can check with a patients insurance plan about their coverage for Jakafi and any out-of-pocket costs required.
We can help patients understand how their insurance plan works and provide information about prior authorization requirements. We can also offer information about appealing insurance denials or restrictions.
We can arrange to have the patients prescription for Jakafi filled by an approved specialty pharmacy and delivered directly to either the patients home or Healthcare Professionals office.
For patients with commercial or private prescription drug coverageeligible patients pay as little as $0 per month, subject to certain limits.*
Free product is offered to eligible patients who are uninsured or underinsured for Jakafi.
For insurance coverage delays, eligible patients can receive a free short-term supply of Jakafi.
Patient Education and Support
Through our call center, IncyteCARES representatives can answer patient questions about their condition and Jakafi.
Connection to Other Support Services
For patients who need additional support beyond what we can provide directly, IncyteCARES can offer information about other independent organizations that may be able to help.
How To Use Jakafi
Read the Patient Information Leaflet if available from your pharmacist before you start taking ruxolitinib and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Take this medication by mouth with or without food as directed by your doctor, usually twice daily. If you are unable to swallow the tablets, ask your doctor about other ways to take this medication.
The dosage is based on your medical condition, laboratory test results, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use .
Avoid eating grapefruit or drinking grapefruit juice while using this medication unless your doctor or pharmacist says you may do so safely. Grapefruit can increase the chance of side effects with this medicine. Ask your doctor or pharmacist for more details.
To reduce your risk of side effects, your doctor may direct you to start this medication at a low dose and gradually increase your dose. Follow your doctor’s instructions carefully. Do not increase your dose or use this drug more often or for longer than prescribed. Your condition will not improve any faster, and your risk of side effects will increase.
Use this medication regularly to get the most benefit from it. To help you remember, take it at the same times each day.
Tell your doctor if your symptoms do not improve or if they worsen.
Don’t Miss: Will Medicare Pay For Dental
What Is The Magnitude Of Potential Savings For Part D Enrollees With Out
- As expected, a $2,000 cap on out-of-pocket spending would generate larger savings than a $3,100 cap. Average out-of-pocket spending was $3,216 among the 1.2 million Part D enrollees with out-of-pocket spending above $2,000 in 2019. These enrollees would have saved $1,216, or 38% of their annual costs, on average, if a $2,000 cap had been in place in 2019, but only $116, or 4%, under a $3,100 cap .
- Medicare Part D enrollees with higher-than-average out-of-pocket costs could save substantial amounts with an out-of-pocket spending cap. For example, the top 10% of beneficiaries with average out-of-pocket costs for their medications above $2,000 in 2019 who spent at least $5,348 would have saved $3,348 in out-of-pocket costs with a $2,000 cap and $2,248 with a $3,100 cap. The top 1% of beneficiaries with average out-of-pocket costs above $2,000 who spent nearly $12,000 or more would have saved $9,880 with a $2,000 cap and $8,780 with a cap of $3,100.
Figure 2: Estimated Cost Savings Under Proposed Medicare Part D Out-of-Pocket Spending Caps Could Be Substantial for Some Part D Enrollees with High Out-of-Pocket Costs
Does Medicare Cover Jakafi
Jakafi is an oral medication prescribed to manage specific bone marrow conditions, such as polycythemia vera. The drugs mission is to stop the body from generating substances known as growth factors. Unrestrained, these protein molecules stimulate cells to grow and divide, and are also responsible for the blood cell and spleen issues that frequently arise with bone marrow disorders.
Though the drug is not a cure, it can alleviate certain symptoms, such as abdominal discomfort, pain that targets the area under the left ribs, premature satiety, night sweats, itchiness, and bone or muscle pain. Jakafi is the first and only medicine approved by the Food and Drug Administration for the treatment of these patients.
Medicare Coverage for JakafiMedicare Part D plan participants need to check their plans formulary, or list of covered drugs, to check for coverage of Jakafi. You can also search for Jakafi under its generic name, ruxolitinib. Drug coverage and costs can vary between plans. If you have Original Medicare, you can enroll in a stand-alone Prescription Drug Plan . Alternatively, you can get your Medicare benefits from a Medicare Advantage plan.
MA plans will include at least the same Part A and Part B benefits as Original Medicare, but many Medicare Advantage plans include additional benefits, such as prescription drug coverage. The best time to enroll in Part D prescription drug coverage is during your initial period of eligibility to avoid a late enrollment penalty.
Recommended Reading: What Age Can I Get On Medicare
How Many Medicare Part D Enrollees Incurred Out
- In 2019, nearly 1 million more Part D enrollees incurred out-of-pocket costs for their medications above $2,000, the proposed out-of-pocket spending limit in H.R. 3, than above $3,100, the proposed out-of-pocket spending limit in the GOP drug legislation and the 2019 Senate Finance Committee bill . Overall, 1.2 million Part D enrollees in 2019 incurred annual out-of-pocket costs for their medications above $2,000, while 0.3 million spent more than $3,100 out of pocket.
- The number of Medicare Part D enrollees who have annual out-of-pocket costs greater than $2,000 or $3,100 in a future year, when a proposed cap could be implemented, is likely to exceed our estimates that are based on 2019 claims data, considering enrollment growth, rising drug prices for existing drugs, and the availability of new, higher-priced medications covered by Part D. Moreover, while adding an out-of-pocket cap to Part D may affect a relatively small number of enrollees in any given year, it would help a larger share and number over time, as our previous analysis showed.
Potential Savings For Medicare Part D Enrollees Under Proposals To Add A Hard Cap On Out
Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Part D enrollees are required to pay 5% of their total drug costs in the catastrophic phase unless they qualify for Part D Low-Income Subsidies . In 2021, the catastrophic threshold is set at $6,550 in out-of-pocket drug costs, which includes what beneficiaries themselves pay and the value of the manufacturer discount on the price of brand-name drugs in the coverage gap , which counts towards this amount. This lack of a hard out-of-pocket spending cap can expose Part D enrollees to thousands of dollars in out-of-pocket costs if they take several costly medications or even just one expensive drug.
Also Check: Is Dexcom G6 Cgm Covered By Medicare
